Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > CASP8(Gene name) > Human
  • Add your favorite
  • CASP8 (Gene name),
  • Caspase-8 (Protein name ),  CASP8_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    CASP8(MCH5);
    Protein name:
    Caspase-8(CASP-8);
    Alternative:
    Apoptotic protease Mch-5;Apoptotic cysteine protease;FADD-homologous ICE/ced-3-like protease;CAP4;ICE-like apoptotic protease 5;FADD-like ICE(FLICE);MORT1-associated ced-3 homolog(MACH);
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Heterotetramer that consists of two anti-parallel arranged heterodimers, each one formed by a 18 kDa (p18) and a 10 kDa (p10) subunit. Interacts with FADD, CFLAR and PEA15. Isoform 9 interacts at the endoplasmic reticulum with a complex containing BCAP31, BAP29, BCL2 and/or BCL2L1. Interacts with TNFAIP8L2.
    Function:
    Most upstream protease of the activation cascade of caspases responsible for the TNFRSF6/FAS mediated and TNFRSF1A induced cell death. Binding to the adapter molecule FADD recruits it to either receptor. The resulting aggregate called death-inducing signaling complex (DISC) performs CASP8 proteolytic activation. The active dimeric enzyme is then liberated from the DISC and free to activate downstream apoptotic proteases. Proteolytic fragments of the N-terminal propeptide (termed CAP3, CAP5 and CAP6) are likely retained in the DISC. Cleaves and activates CASP3, CASP4, CASP6, CASP7, CASP9 and CASP10. May participate in the GZMB apoptotic pathways. Cleaves ADPRT. Hydrolyzes the small-molecule substrate, Ac-Asp-Glu-Val-Asp-|-AMC. Likely target for the cowpox virus CRMA death inhibitory protein. Isoform 5, isoform 6, isoform 7 and isoform 8 lack the catalytic site and may interfere with the pro-apoptotic activity of the complex.
    Subcellular Location:
    Cytoplasm
    Protein Attributes:
    Sequence length:
    479
    Sequence:
    50:
    MDFSRNLYDI | GEQLDSEDLA | SLKFLSLDYI | PQRKQEPIKD | ALMLFQRLQE | 
    100:
    KRMLEESNLS | FLKELLFRIN | RLDLLITYLN | TRKEEMEREL | QTPGRAQISA | 
    150:
    YRVMLYQISE | EVSRSELRSF | KFLLQEEISK | CKLDDDMNLL | DIFIEMEKRV | 
    200:
    ILGEGKLDIL | KRVCAQINKS | LLKIINDYEE | FSKERSSSLE | GSPDEFSNGE | 
    250:
    ELCGVMTISD | SPREQDSESQ | TLDKVYQMKS | KPRGYCLIIN | NHNFAKAREK | 
    300:
    VPKLHSIRDR | NGTHLDAGAL | TTTFEELHFE | IKPHDDCTVE | QIYEILKIYQ | 
    350:
    LMDHSNMDCF | ICCILSHGDK | GIIYGTDGQE | APIYELTSQF | TGLKCPSLAG | 
    400:
    KPKVFFIQAC | QGDNYQKGIP | VETDSEEQPY | LEMDLSSPQT | RYIPDEADFL | 
    450:
    LGMATVNNCV | SYRNPAEGTW | YIQSLCQSLR | ERCPRGDDIL | TILTEVNYEV | 
    479:
    SNKDDKKNMG | KQMPQPTFTL | RKKLVFPSD
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    UniGene:
    KEGG:
    MIM:
    SMR:
    Pfam:
    String:
    Uniprot:
     
    FOR
    ELISA Kit for Human CASP-8
    Cat.:
    E2015m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human CASP-8
    Cat.:
    E2015h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human CASP-8
    Cat.:
    U2015h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human CASP-8
    Cat.:
    U2015m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    Polyclonal Antibody for Human CASP-8
    Cat.:
    P2015Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human CASP-8
    Cat.:
    P2015Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human CASP-8
    Monoclonal Antibody for Human CASP-8
    Protein for Human CASP-8
    Protein for Human CASP-8

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    s
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision

    Intra-assay Precision (Precision within an assay):Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

    Intra-Assay CV: ≤7.6%

    Inter-assay Precision (Precision between assays):Three samples of known concentration were tested in five separate assays to assess inter-assay precision.

    Inter-Assay CV: ≤9.7%

    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.

    Intra-assay Precision (Precision within an assay):Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

    Intra-Assay CV: ≤3.9%

    Inter-assay Precision (Precision between assays):Three samples of known concentration were tested in five separate assays to assess inter-assay precision.

    Inter-Assay CV: ≤7.7%

    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery

    Recovery was determined by spiking various levels of CASP8 into serum and plasma .

    Sample Type

    Average(%)

    Recovery Range(%)

    Serum

    99

    95-103

    Plasma

    98

    94-102

     

     

     

     

    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.

    Recovery was determined by spiking various levels of ACE into serum and plasma .

    Sample Type

    Average(%)

    Recovery Range(%)

    Serum

    99

    91-103

    Plasma

    98

    93-106

     

     

     

     

    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity

     

    The linearity of the kit was assayed by testing samples spiked with appropriate concentration of CASP8E and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.  

     

    Sample

    1:2

    1:4

    1:8

    1:16

    serum(n=5)

    93-104%

    92-106%

    94-105%

    95-103%

    EDTA plasma(n=5)

    94-102%

    93-105%

    96-101%

    93-104%

    heparin plasma(n=5)

    90-105%

     

    91-106%

    92-104%

    95-103%

     

    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.

     

    The linearity of the kit was assayed by testing samples spiked with appropriate concentration of ACE and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.  

     

    Sample

    1:2

    1:4

    1:8

    1:16

    serum(n=5)

    92-105%

    90-101%

    95-105%

    92-109%

    EDTA plasma(n=5)

    89-95%

    93105%

    89-94%

    90-106%

    heparin plasma(n=5)

    93-104%

     

    94-110%

    101-111%

    91-110%

     

    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death."
      Boldin M.P. , Goncharov T.M. , Goltsev Y.V. , Wallach D.
      Cell85:803-815(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 5; 6; 7 AND 8)
      tissue: B-cell.
      tissue: Thymus.
    2. 2.
      "FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex."
      Muzio M. , Chinnaiyan A.M. , Kischkel F.C. , O'Rourke K. , Shevchenko A. , Ni J. , Scaffidi C. , Bretz J.D. , Zhang M. , Gentz R. , Mann M. , Krammer P.H. , Peter M.E. , Dixit V.M.
      Cell85:817-827(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);PARTIAL PROTEIN SEQUENCE
    3. 3.
      "In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains."
      Fernandes-Alnemri T. , Armstrong R.C. , Krebs J.F. , Srinivasula S.M. , Wang L. , Bullrich F. , Fritz L.C. , Trapani J.A. , Tomaselli K.J. , Litwack G. , Alnemri E.S.
      Proc. Natl. Acad. Sci. U.S.A.93:7464-7469(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4);VARIANT HIS-285
      tissue: T-cell.
    4. 4.
      "FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis."
      Srinivasula S.M. , Ahmad M. , Ottilie S. , Bullrich F. , Banks S. , Wang Y. , Fernandes-Alnemri T. , Croce C.M. , Litwack G. , Tomaselli K.J. , Armstrong R.C. , Alnemri E.S.
      J. Biol. Chem.272:18542-18545(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2);VARIANT HIS-285
    5. 5.
      "Structure and chromosome localization of the human CASP8 gene."
      Grenet J. , Teitz T. , Wei T. , Valentine V. , Kidd V.J.
      Gene226:225-232(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
    6. 6.
      "Cloning and characterization of three novel genes, ALS2CR1, ALS2CR2, and ALS2CR3, in the juvenile amyotrophic lateral sclerosis (ALS2) critical region at chromosome 2q33-q34: candidate genes for ALS2."
      Hadano S. , Yanagisawa Y. , Skaug J. , Fichter K. , Nasir J. , Martindale D. , Koop B.F. , Scherer S.W. , Nicholson D.W. , Rouleau G.A. , Ikeda J.-E. , Hayden M.R.
      Genomics71:200-213(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA];VARIANT HIS-285
    7. 7.
      "Characterization of caspase-8L: a novel isoform of caspase-8 that behaves as an inhibitor of the caspase cascade."
      Himeji D. , Horiuchi T. , Tsukamoto H. , Hayashi K. , Watanabe T. , Harada M.
      Blood99:4070-4078(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7);FUNCTION (ISOFORM 7)
      tissue: Leukocyte.
    8. 8.
      "The procaspase-8 isoform, procaspase-8L, recruited to the BAP31 complex at the endoplasmic reticulum."
      Breckenridge D.G. , Nguyen M. , Kuppig S. , Reth M. , Shore G.C.
      Proc. Natl. Acad. Sci. U.S.A.99:4331-4336(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 9);INTERACTION OF ISOFORM 9 WITH BCAP31 AT THE ENDOPLASMIC RETICULUM
    9. 9.
      NIEHS SNPs program
      Submitted (2006-01) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA];VARIANTS THR-219 AND HIS-285
    10. 10.
      "Generation and annotation of the DNA sequences of human chromosomes 2 and 4."
      Hillier L.W. , Graves T.A. , Fulton R.S. , Fulton L.A. , Pepin K.H. , Minx P. , Wagner-McPherson C. , Layman D. , Wylie K. , Sekhon M. , Becker M.C. , Fewell G.A. , Delehaunty K.D. , Miner T.L. , Nash W.E. , Kremitzki C. , Oddy L. , Du H. , more...
      Nature434:724-731(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    11. 11.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7)
      tissue: Leukocyte.
    12. 12.
      "Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases."
      Srinivasula S.M. , Ahmad M. , Fernandes-Alnemri T. , Litwack G. , Alnemri E.S.
      Proc. Natl. Acad. Sci. U.S.A.93:14486-14491(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PARTIAL PROTEIN SEQUENCE;PROTEOLYTIC PROCESSING
    13. 13.
      "FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens."
      Muzio M. , Salvesen G.S. , Dixit V.M.
      J. Biol. Chem.272:2952-2956(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION
    14. 14.
      "FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)."
      Medema J.P. , Scaffidi C. , Kischkel F.C. , Shevchenko A. , Mann M. , Krammer P.H. , Peter M.E.
      EMBO J.16:2794-2804(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEOLYTIC PROCESSING
    15. 15.
      "Dominant expression of a novel splice variant of caspase-8 in human peripheral blood lymphocytes."
      Horiuchi T. , Himeji D. , Tsukamoto H. , Harashima S. , Hashimura C. , Hayashi K.
      Biochem. Biophys. Res. Commun.272:877-881(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CHARACTERIZATION (ISOFORM 7)
    16. 16.
      "p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum."
      Ng F.W.H. , Nguyen M. , Kwan T. , Branton P.E. , Nicholson D.W. , Cromlish J.A. , Shore G.C.
      J. Cell Biol.139:327-338(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH BCL2; BCL2L1 AND BCAP31
    17. 17.
      "PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis."
      Condorelli G. , Vigliotta G. , Cafieri A. , Trencia A. , Andalo P. , Oriente F. , Miele C. , Caruso M. , Formisano P. , Beguinot F.
      Oncogene18:4409-4415(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH PEA15
    18. 18.
      "A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation."
      Skaletskaya A. , Bartle L.M. , Chittenden T. , McCormick A.L. , Mocarski E.S. , Goldmacher V.S.
      Proc. Natl. Acad. Sci. U.S.A.98:7829-7834(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH HHV-5 PROTEIN UL36
    19. 19.
      "An unappreciated role for RNA surveillance."
      Hillman R.T. , Green R.E. , Brenner S.E.
      Genome Biol.5:R8.1-R8.16(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S)
    20. 20.
      "Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth."
      McDonald E.R. III , El-Deiry W.S.
      Proc. Natl. Acad. Sci. U.S.A.101:6170-6175(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH RFFL AND RNF34
    21. 21.
      "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells."
      Rush J. , Moritz A. , Lee K.A. , Guo A. , Goss V.L. , Spek E.J. , Zhang H. , Zha X.-M. , Polakiewicz R.D. , Comb M.J.
      Nat. Biotechnol.23:94-101(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-334;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    22. 22.
      "Role of FLASH in caspase-8-mediated activation of NF-kappaB: dominant-negative function of FLASH mutant in NF-kappaB signaling pathway."
      Jun J.-I. , Chung C.-W. , Lee H.-J. , Pyo J.-O. , Lee K.N. , Kim N.-S. , Kim Y.S. , Yoo H.-S. , Lee T.-H. , Kim E. , Jung Y.-K.
      Oncogene24:688-696(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: MUTAGENESIS OF ASP-73
    23. 23.
      "FLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodies."
      Milovic-Holm K. , Krieghoff E. , Jensen K. , Will H. , Hofmann T.G.
      EMBO J.26:391-401(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH CASP8P2
    24. 24.
      "Cdk1/cyclin B1 controls Fas-mediated apoptosis by regulating caspase-8 activity."
      Matthess Y. , Raab M. , Sanhaji M. , Lavrik I.N. , Strebhardt K.
      Mol. Cell. Biol.30:5726-5740(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION AT SER-387 BY CDK1
    25. 25.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    26. 26.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH E.COLI NLEF;CATALYTIC ACTIVITY;FUNCTION;ENZYME REGULATION
    27. 27.
      "The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis."
      Blanchard H. , Kodandapani L. , Mittl P.R.E. , Di Marco S. , Krebs J.F. , Wu J.C. , Tomaselli K.J. , Gruetter M.G.
      Structure7:1125-1133(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS)
    28. 28.
      "The atomic-resolution structure of human caspase-8, a key activator of apoptosis."
      Watt W. , Koeplinger K.A. , Mildner A.M. , Heinrikson R.L. , Tomasselli A.G. , Watenpaugh K.D.
      Structure7:1135-1143(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (1.2 ANGSTROMS) OF 211-479;SUBUNIT
    29. 29.
      "Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency."
      Chun H.J. , Zheng L. , Ahmad M. , Wang J. , Speirs C.K. , Siegel R.M. , Dale J.K. , Puck J. , Davis J. , Hall C.G. , Skoda-Smith S. , Atkinson T.P. , Straus S.E. , Lenardo M.J.
      Nature419:395-399(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CASP8D TRP-248
    30. 30.
      "Association of a common variant of the CASP8 gene with reduced risk of breast cancer."
      MacPherson G. , Healey C.S. , Teare M.D. , Balasubramanian S.P. , Reed M.W.R. , Pharoah P.D. , Ponder B.A.J. , Meuth M. , Bhattacharyya N.P. , Cox A.
      J. Natl. Cancer Inst.96:1866-1869(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HIS-285;PROTECTION AGAINST BREAST CANCER
    31. 31.
      "A common coding variant in CASP8 is associated with breast cancer risk."
      The Kathleen Cunningham foundation consortium for research into familial breast cancer , Breast cancer association consortium , Cox A. , Dunning A.M. , Garcia-Closas M. , Balasubramanian S. , Reed M.W.R. , Pooley K.A. , Scollen S. , Baynes C. , Ponder B.A.J. , Chanock S. , Lissowska J. , Brinton L. , Peplonska B. , Southey M.C. , Hopper J.L. , McCredie M.R.E. , more...
      Nat. Genet.39:352-358(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HIS-285;PROTECTION AGAINST BREAST CANCER
    32. 33.
      "A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers."
      Sun T. , Gao Y. , Tan W. , Ma S. , Shi Y. , Yao J. , Guo Y. , Yang M. , Zhang X. , Zhang Q. , Zeng C. , Lin D.
      Nat. Genet.39:605-613(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN PROTECTION AGAINST LUNG CANCER
    33. 34.
      "Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma."
      Li C. , Zhao H. , Hu Z. , Liu Z. , Wang L.-E. , Gershenwald J.E. , Prieto V.G. , Lee J.E. , Duvic M. , Grimm E.A. , Wei Q.
      Hum. Mutat.29:1443-1451(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HIS-285;RISK FACTOR FOR CUTANEOUS MELANOMA
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Tumor necrosis Alpha Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter